EUVIMEDEUVIMED entdecken
Open Access

Development and evaluation of a novel deuterated fluorine-18 PET tracer for MAO-B imaging

Chongyi Huang, Huiyi Wei, Haige Yi, Guocong Li, Weiyuan Lin, Taoqian Zhao, Yinlong Li, Steven H Liang, Hao Xu, Lu Wang

American Journal of Nuclear Medicine and Molecular Imaging · 2026 · 16 (2) · 90-99

DOI: 10.62347/crah2142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Chongyi Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoamine oxidase B (MAO-B) is a key astrocytic biomarker implicated in neuro-inflammation and neurodegenerative diseases. This study reports the development and evaluation of novel fluorine-18 (18F) PET radiotracers for selective MAO-B imaging by exploiting deuteration strategies to address metabolic instability of existing probes. A literature compound [18F]GEH200449 ([18F]4) was synthesized through redesigned labeling precursor, and its deuterated analogue, [18F]4-D2, was prepared to improve metabolic stability. Systematic evaluation using PET imaging, radiometabolite analysis, and autoradiography was performed. While both tracers demonstrated favorable blood-brain barrier penetration, they didn't exhibit region-specific binding consistent with MAO-B distribution in vivo. Furthermore, [18F]4 underwent substantial metabolic degradation in both central and peripheral compartments, and deuteration failed to provide significant stabilization in [18F]4-D2. Autoradiography further revealed non-selective binding of [18F]4-D2 to both MAO isoforms. Overall, the translational potential of [18F]4 and [18F]4-D2 remains limited by poor metabolic stability and insufficient target selectivity. Future tracer design should focus on pharmacophore optimization to achieve reliable and selective MAO-B PET imaging.

Schlagwörter

Stichwörter der Autor:innen

Fluorine-18Monoamine oxidase BPETdeuteriumradiometabolites

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Nuclear Medicine, T…

Zitieren

APA

Huang, C., Wei, H., Yi, H., Li, G., Lin, W., Zhao, T., Li, Y., Liang, S. H., Xu, H., & Wang, L. (2026). Development and evaluation of a novel deuterated fluorine-18 PET tracer for MAO-B imaging. American Journal of Nuclear Medicine and Molecular Imaging, 16(2), 90-99. https://doi.org/10.62347/crah2142

Vancouver

Huang C, Wei H, Yi H, Li G, Lin W, Zhao T, et al. Development and evaluation of a novel deuterated fluorine-18 PET tracer for MAO-B imaging. American Journal of Nuclear Medicine and Molecular Imaging. 2026;16(2):90-99. doi:10.62347/crah2142

BibTeX
@article{Huang2026,
  author = {Huang, Chongyi and Wei, Huiyi and Yi, Haige and Li, Guocong and Lin, Weiyuan and Zhao, Taoqian and Li, Yinlong and Liang, Steven H and Xu, Hao and Wang, Lu},
  title = {Development and evaluation of a novel deuterated fluorine-18 PET tracer for MAO-B imaging},
  journal = {American Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {90--99},
  doi = {10.62347/crah2142}
}
Kostenlos starten →